Smruthi Organics' Financial Performance Declines in Q1 FY25, Negative Outlook Ahead
Smruthi Organics, a microcap pharmaceutical company, recently announced its financial results for the quarter ending June 2024. The company’s stock has been given a ‘Sell’ call by MarketsMOJO, indicating a negative outlook for the company’s performance.
According to the financial report, Smruthi Organics has seen a decline in its overall financial performance in the last quarter. The company’s score has fallen from 3 to -10 in the last three months, indicating a significant decrease in its financial health.
One of the major factors contributing to this decline is the Profit Before Tax (PBT) less Other Income, which has fallen by 201.8% compared to the average PBT of the previous four quarters. This trend is expected to continue in the near term, indicating a negative outlook for the company’s profitability.
Similarly, the Profit After Tax (PAT) has also seen a significant decline of 202.5% compared to the average PAT of the previous four quarters. This indicates a decrease in the company’s net income and a negative trend in the near future.
Moreover, the company’s Net Sales have also fallen by 14.5% compared to the average Net Sales of the previous four quarters. This decline in sales is a cause for concern and could impact the company’s overall financial performance.
Another concerning factor is the Debtors Turnover Ratio, which is at its lowest in the last five half-yearly periods. This indicates that the company’s pace of settling its debtors has slowed down, which could have a negative impact on its cash flow.
Overall, the financial results for the quarter ending June 2024 do not paint a positive picture for Smruthi Organics. Investors should carefully consider these factors before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
